Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optineurin in primary open angle glaucoma.

Mansoor Sarfarazi1, Tayebeh Rezaie

  • 1Molecular Ophthalmic Genetics Laboratory, University of Connecticut Health Center, Farmington, CT 06030, USA. mansoor@neuron.uchc.edu

Ophthalmology Clinics of North America
|January 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ClinVar: updates to support classifications of both germline and somatic variants.

Nucleic acids research·2024
Same author

Ocular genetics in the genomics age.

American journal of medical genetics. Part C, Seminars in medical genetics·2020
Same author

Targeted Screening for Predominant CYP1B1 Mutations in Primary Congenital Glaucoma.

Journal of ophthalmic & vision research·2018
Same author

Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models.

Cell death & disease·2016
Same author

Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration.

Stem cells (Dayton, Ohio)·2016
Same author

Common Molecular Challenges in Glaucoma.

Journal of ophthalmic & vision research·2015

Mutations in the Optineurin (OPTN) gene are a significant cause of adult-onset primary open-angle glaucoma (POAG) and late-onset primary open-angle glaucoma (LPG). Identifying OPTN mutations can enable early diagnosis and intervention for glaucoma, preventing vision loss.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Primary open-angle glaucoma (POAG) and late-onset primary open-angle glaucoma (LPG) affect millions in the US, with many undiagnosed.
  • Optineurin (OPTN) mutations are implicated in a substantial proportion of familial POAG/LPG cases.

Purpose of the Study:

  • To investigate the role of Optineurin (OPTN) gene mutations in the etiology of POAG and LPG.
  • To assess the potential of OPTN as a diagnostic tool for early detection of glaucoma.

Main Methods:

  • Analysis of OPTN gene mutations in families with POAG/LPG.
  • Review of existing literature on OPTN mutations and their prevalence in different glaucoma populations.

Main Results:

Related Experiment Videos

  • OPTN mutations are a principal cause of the adult-onset POAG/LPG phenotype in specific pedigrees.
  • Limited data suggest OPTN mutations account for a smaller fraction of high-pressure POAG cases.
  • OPTN's interaction with other proteins suggests pathways involved in apoptosis, inflammation, and vasoconstriction.

    • Conclusions:

    • OPTN is a significant adult-onset glaucoma gene, offering potential for molecular diagnostics.
    • Early identification of at-risk individuals through OPTN screening could lead to timely treatment and prevention of vision loss.
    • Further functional studies are needed to elucidate the exact mechanisms by which OPTN mutations cause glaucoma.